Glaxosmithkline Consumer Healthcare Ltd. [Merged]

₹10,732.60

up-down-arrow496.30 (4.85%)

As on 15-Apr-2020IST

Glaxosmithkline [Merged] Share Price

Compare

High:loading Low:loading Return: loading

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 10,310.00 High: 10,850.00

52 Week Range

Low: -- High: --

Liquidityliquidity

Low Moderate High

Fundamentals

  • Market capMarket cap information

    ₹45,225 Cr

  • Revenue (TTM)Revenue (TTM) information

    ₹4,984 Cr

  • Net Profit (TTM)Net Profit (TTM) information

    ₹622 Cr

  • ROEROE information

    25.9 %

  • ROCEROCE information

    39.9 %

  • P/E RatioP/E Ratio information

    39.1

  • P/B RatioP/B Ratio information

    10.2

  • Industry P/EIndustry P/E information

    22.74

  • EV/EBITDAEV/EBITDA information

    24

  • Div. YieldDiv. Yield information

    1 %

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    ₹--

  • EPSEPS information

    ₹274.8

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    42,055,538

10 Years Aggregate

CFO

₹5,497.78 Cr

EBITDA

₹7,068.81 Cr

Net Profit

₹5,609.81 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Glaxosmithkline [Merged]
29.2 21.5 23.0 49.0 26.5 11.3 21.5
BSE Sensex*
-9.4 -8.1 -9.3 3.4 9.8 9.0 12.0
BSE FMCG#
-12.4 -7.1 -11.8 -5.9 3.0 7.6 8.9
As on 15-Apr-2020  |  *As on 18-Mar-2026  |  #As on 18-Mar-2026
Company
2019
2018
2017
2016
2015
2014
Glaxosmithkline [Merged]
9.7 18.0 30.7 -21.4 9.9 32.6
BSE Sensex
14.4 5.9 27.9 1.9 -5.0 29.9
BSE FMCG
-3.6 10.5 31.5 3.3 1.4 18.3

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Glaxosmithkline [Merged]
10,732.6 45,225.1 4,984.3 1,155.8 23.9 28 39.1 10.2
1,098.4 6,849.0 3,960.4 265.2 6.6 18.5 25.8 4.3
978.9 21,777.0 9,624.4 348.3 6.4 19.6 62.5 11.5
320.2 2,975.5 4,416.9 167.1 4.9 16.2 18.1 2.8
32.5 92.3 338.8 22.4 1.9 55.1 4.1 1.6
201.7 2,528.5 3,790.4 129.0 5.0 12.1 19.6 2.1
9.0 32.1 0.6 -0.1 -45.5 -1 -- 4.8
299.3 321.8 326.2 15.7 11.6 11.7 20.5 2.3
4,680.6 3,368.7 1,359.7 122.3 11.4 16.5 27.6 4.7
29.8 60.9 167.2 -7.2 -3.9 -10.9 -- 1.0

Shareholding Pattern

View Details
loading...

News & Analysis

All News

About Glaxosmithkline [Merged]

Manufacture of malted foods including foods for infants and handicapped

  • Incorporated

    1958

  • Chairman

    P Dwarakanath

  • Managing Director

    Navneet Saluja

  • Group

    Glaxosmithkline - MNC

  • Headquarters

    Nabha, Punjab

  • Website

    http://www.gsk-ch.in/

Edit peer-selector-edit
loading...
loading...

Announcements

View Announcements

FAQs for Glaxosmithkline [Merged]

The share price of Glaxosmithkline Consumer Healthcare Ltd [Merged] is ₹10,732.60 (NSE) and ₹10,753.65 (BSE) as of 15-Apr-2020 IST. Glaxosmithkline Consumer Healthcare Ltd [Merged] has given a return of 26.53% in the last 3 years.

The P/E ratio of Glaxosmithkline Consumer Healthcare Ltd [Merged] is 39.13 times as on 15-Apr-2020, a 72 premium to its peers’ median range of 22.74 times.
The P/B ratio of Glaxosmithkline Consumer Healthcare Ltd [Merged] is 10.19 times as on 15-Apr-2020, a 170 premium to its peers’ median range of 3.77 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2019
30.86
7.41
2018
36.61
7.36
2017
33.04
6.95
2016
36.93
9.07
2015
45.40
12.54

The 52-week high and low of Glaxosmithkline Consumer Healthcare Ltd [Merged] are Rs -- and Rs -- as of 19-Mar-2026.

Glaxosmithkline Consumer Healthcare Ltd [Merged] has a market capitalisation of ₹ 45,225 Cr as on 15-Apr-2020. As per SEBI classification, it is a company.

Before investing in Glaxosmithkline Consumer Healthcare Ltd [Merged], assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.